These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16037701)

  • 1. Prognostic factors in a recent series of patients treated with radical cystectomy for bladder cancer.
    Novara G; Ficarra V; Alrabi N; Dalpiaz O; Martignoni G; Galfano A; Cavalleri S; Artibani W
    Urol Int; 2005; 75(1):10-6. PubMed ID: 16037701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
    Palmieri F; Brunocilla E; Bertaccini A; Guidi M; Pernetti R; Morselli-Labate AM; Martorana G
    Anticancer Res; 2010 Jul; 30(7):2973-6. PubMed ID: 20683041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma.
    Ficarra V; Dalpiaz O; Alrabi N; Novara G; Galfano A; Artibani W
    BJU Int; 2005 Apr; 95(6):786-90. PubMed ID: 15794783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
    Holzbeierlein JM; Lopez-Corona E; Bochner BH; Herr HW; Donat SM; Russo P; Dalbagni G; Sogani PC
    J Urol; 2004 Sep; 172(3):878-81. PubMed ID: 15310988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of bladder cancer patients undergoing radical cystectomy].
    Kato Y; Hasegawa Y; Wakita T; Hayashi N
    Hinyokika Kiyo; 2005 Nov; 51(11):719-25. PubMed ID: 16363702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy.
    Masson-Lecomte A; Vordos D; Hoznek A; Yiou R; Allory Y; Abbou CC; de la Taille A; Salomon L
    Ann Surg Oncol; 2013 Apr; 20(4):1389-94. PubMed ID: 23208127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort.
    Bassi P; Ferrante GD; Piazza N; Spinadin R; Carando R; Pappagallo G; Pagano F
    J Urol; 1999 May; 161(5):1494-7. PubMed ID: 10210380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.
    Horikawa Y; Kumazawa T; Narita S; Inoue T; Yuasa T; Matsuura S; Nanjo H; Satoh S; Tsuchiya N; Habuchi T
    Int J Clin Oncol; 2007 Apr; 12(2):131-6. PubMed ID: 17443281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer.
    Shirotake S; Kikuchi E; Matsumoto K; Yazawa S; Kosaka T; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2010 Mar; 40(3):247-51. PubMed ID: 19887521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.